Vital Therapies, Inc., a biotherapeutic company, focuses on developing cell-based therapies for the treatment of acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is based in San Diego, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [04/15/2019 10:30 PDT] Vital Therapies, Inc. (NASDAQ:VTL), Up By 100.00% ($22.39) After BUYINS.NET SqueezeTrigger Report Released on Monday, April 15th 2019 at a Price of $22.389.
• [04/15/2019 10:29 PDT] VTL SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [04/12/2019 21:21 PDT] Market Maker Surveillance Report. VTL, Bullishly Biased Price Friction For Friday, April 12th 2019
• [04/11/2019 07:49 PDT] VTL Expected to Trade Down After Bearish Patterns Develop
• [04/09/2019 08:17 PDT] Vital Therapies, Inc. (NASDAQ:VTL), Up By 100.00% ($0.72) From $0.720 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/09/2019 07:55 PDT] VTL Expected to Trade Up After Bullish Patterns Develop